Abstract It is unknown how lifetime marijuana use affects different proinflammatory cytokines. The purpose of the current study is to explore potential differential effects of lifetime marijuana use on interleukin-1 alpha (IL-1a) and tumor necrosis factor (TNF) in a community based sample. Participants included 168 African American adults (51 % female, median age = 47 years). Upon study entry, blood was drawn and the participants completed questions regarding illicit drug use history whose answers were used to create three groups: lifetime non-drug users (n = 77), lifetime marijuana only users (n = 46) and lifetime marijuana and other drug users (n = 45). In the presence of demographic and physiological covariates, non-drug users were approximately two times more likely (AOR 2.73, CI 1.18, 6.31; p = .03) to have higher TNF levels than marijuana only users. Drug use was not associated with IL-1a. The influence of marijuana may be selective in nature, potentially localizing around innate immunity and the induction of cellular death.
Introduction
Marijuana is the most widely used drug in the United States and the usage prevalence has significantly increased over the past decade (NIDA, 2012) . This increase in recent years is also evident given the legalization of recreational marijuana usage in two states and legalized medicinal usage in 23 states. With increases in both medicinal and recreational usage of marijuana in the United States, it is critical to continue examining the healthy and deleterious influence of marijuana use. Marijuana's therapeutic usage has garnered much attention in the clinical and experimental literature over the past decade (Aggarwal et al., 2009; Arevalo-Martin, Vela, Molina-Holgado, Borrell, & Guaza, 2003; Friedman & Klein, 1999; Klein, 2005) . Specifically, researchers have begun to explore the relationship between marijuana use and immune function (Baldwin et al., 1997; Roth, Baldwin, & Tashkin, 2002) . However, the vast majority of this literature focus is at the cellular level, which posits marijuana's immunosuppressive effects on innate immunity (Reiss, 2010; Ribeiro et al., 2012) . To date, very few studies have examined the recreational use of marijuana and its relationship with proinflammatory cytokines at the public health or epidemiological level.
Dysregulation of proinflammatory cytokines may lead to increases in peripheral cytokine levels, leading to the condition called inflammation. Inflammation is a public health concern due to its' association with many of the leading causes of death, including heart disease, cancer, stroke, diabetes, and Alzheimer's disease (Glass, Saijo, Winner, Marchetto, & Gage, 2010) . Given the anti-inflammatory constituents in marijuana, researchers and clinicians have begun exploring novel anti-inflammatory therapies utilizing marijuana as a mitigating vector of chronic inflammation based conditions (Albayram et al., 2011; Cabral & Griffin-Thomas, 2009; Canvin & el-Gabalawy, 1999; Gorelick, 2010; Jackson, Diemel, Pryce, & Baker, 2005; Marchetti & Abbracchio, 2005; Raber et al., 1998) . Though the literature examining marijuana use and immunity is still in its infancy, findings suggest that marijuana alters a variety of innate and adaptive immune system responses in both animals and humans (Klein, Friedman, & Specter, 1998; Klein et al., 2003; Matsuda et al., 2005; Ribeiro et al., 2012; Snella, Pross, & Friedman, 1995) . Specifically, previous research examining marijuana's influence on immune cells posits that the nonpsychoactive component cannabidol modulates innate immune responses, such as lymphocytes, natural killer cells, and macrophage function (Baldwin et al., 1997; Chang, Lee, & Lin, 2001; Klein, 2005; Klein et al., 1998) . Overall, marijuana use inhibits macrophage function, which attenuates proinflammatory cytokine proliferation (Klein, Lane, Newton, & Friedman, 2000) . This influence is seen in the reduction production and function of the proinflammatory cytokines interleukin-1 alpha, interleukin-6, and tumor necrosis factor (Cabral & Vasquez, 1992; Klein et al., 2000; Kusher, Dawson, Taylor, & Djeu, 1994; Shivers, Newton, FRiedman, & Klein, 1994; Zurier, Rossetti, Burstein, & Bidinger, 2003) . However, some reports indicate an increase in these cytokines (Fischer-Stenger, Dove Pettit, & Cabral, 1993; Friedman & Klein, 1999; Klein et al., 2000; Shivers et al., 1994) .
Marijuana use activates the cannabinoid system, which has a direct influence on the cytokine network (Klein et al., 2000) . However, research examining the influence of chronic marijuana use on cytokine levels is still sparse. In previous work, we have shown that when compared to their non-drug using counterparts, individuals who report using marijuana in their lifetimes have lower interleukin-6 levels (Keen, Pereira, & Latimer, 2014) . This was the first epidemiological study to identify differences in resting levels of any proinflammatory cytokines based on marijuana use. Given that each proinflammatory cytokine is responsible for variety of different functions, it is imperative to identify the differential effects of marijuana use on each proinflammatory cytokine.
Overall, the literature regarding the relationship between chronic marijuana use and proinflammatory cytokine function is still unclear. Further examination of this relationship in various samples, such as African Americans adults, may inform both clinical and non-clinical efforts in the future. African Americans may present a unique sample, as they represent higher prevalence of many inflammatory based conditions. These conditions include obesity, high life stress, and at high risk for vascular conditions with inflammatory properties (Black, 2003; McDade, Hawkley, & Cacioppo, 2006; Mohamed-Ali et al., 1997) . The purpose of the current study is to examine the associations between self-reported lifetime marijuana use and interleukin-1 alpha and tumor necrosis factor in a community based sample of middle-aged sample of African Americans. We will examine this association utilizing three groups, those who reported no lifetime drug use, individuals who self-reported using marijuana in their lifetime, and those who reported using marijuana in addition to other drugs. We hypothesize that lifetime marijuana use will be associated with lower levels of interleukin-1 alpha and tumor necrosis factor.
Methods

Participants
Data were derived from the parent study entitled, ''Stress and Psychoneuroimmunological Factors in Renal Health and Disease.'' A total of 212 African Americans participated in the parent study. The Minority Organ Tissue Transplant Education Program at Howard University Hospital recruited participants through flyers posted in throughout the hospital and community based health fairs conducted by the Hospital in the Washington, DC metropolitan area. The health fairs were conducted by the Howard University Hospital in order to educate local community in a variety of health concerns, such as heart disease, hypertension, renal health and obesity. Inclusion criteria for the parent study included individuals who were 18 years of age and older with no history of traumatic brain injury or psychiatric diagnosis. The Howard University institutional review board approved this study. For the current study, only those with complete interleukin-1 alpha, tumor necrosis factor, and illicit drug use data (n = 168) were included.
Procedure
Upon entering the Howard University Hospital General Clinical Research Center, researchers obtained informed consent from the participants. After participants gave informed consent, a registered nurse obtained a peripheral venous blood sample of approximately ten milliliters and blood pressure readings. Following these collections, study participants completed a demographic, medical history, behavioral health questionnaire and a psychological battery. Study procedures were conducted in one visit and lasted approximately four hours. Participants were remunerated $50 for their time.
Assessment of illicit drug use
The demographic questionnaire contained questions regarding illicit drug use during the participants' lifetime. The first question read: ''Have you ever used an illicit drug or narcotic?'' Participants who responded ''yes'' then answered a series of follow-up questions that probed for the type of drug(s) used, i.e., ''Have you ever used (insert drug type here; e.g. ''marijuana'')?'' Response choices were ''yes'' or ''no''. The groups non-drug users, marijuana only users, and marijuana and other drugs were created based on these responses.
Quantitation of serum interleukin-1 alpha and tumor necrosis factor A venous blood sample of approximately 10 mL was collected from each participant. Samples were centrifuged for 30 min, aliquoted into six vials, and stored at -70°C at the Howard University General Clinical Research Center until sent to Quest Diagnostics for analyses. Serum interleukin-1 alpha and tumor necrosis factor concentrations (pg/mL) were quantified using Enzyme-Linked Immunosorbent Assay.
Assessment of covariates
Age (in years), sex, years of education, and annual income was collected via a demographic questionnaire administered by a trained researcher. Self-reported medication use was obtained by asking the question ''Are you currently taking any medication?'' Participants were given two options for responses, ''yes'' or ''no''. A trained member of the nursing staff in the General Clinical Research Center obtained height, weight, and blood pressure. Body mass index (BMI) was calculated utilizing the following formula: weight in kilograms divided by height in meters squared.
Data analysis
Data were analyzed using the Statistical Package for Social Sciences, Version 20.0 (SPSS Incorporated). Continuous variables are presented as mean (standard deviation). The outcome variables interleukin-1 alpha and tumor necrosis factor were separated into two groups each at the median with below the median representing ''Low'' values and above the median representing ''High'' values. Categorical prevalence are reported as the frequency of the subsample and the within group percentage. Independent T tests and Chi square test were used to compare respectively continuous and categorical variables between groups. Logistic regression analyses were performed in order to examine the potential associations between illicit drug use and the cytokines in the presence of the covariates. Demographic and physiological covariates that may confound the relationship between drug use and the cytokines were selected based on previous research. 
Results
Unadjusted group differences
As seen in Table 1 , the median age was 47 years of age. The total amount of men (51 %) was similar to the total amount of women (49 %). However, there was a significant difference between the drug using groups on gender (X 2 = 16.81, p = .01) with all groups having more men than women. There was also a significant difference between the groups based on years of education (F[2,165] = 3.40, p = .04), with marijuana and other drug users (M = 13.16, SD = 2.08) having lower levels than their marijuana only (M = 14.13, p = 2.41) and Non-drug user (M = 14.21, p = 2.26). On average, the sample was obese with a BMI of 31.12 kg/m 2 (SD = 8.60 kg/m 2 ). In addition, there were no significant differences among other demographic and physiological variables, including interleukin-1 alpha and tumor necrosis factor.
Unadjusted associations between lifetime drug use and cytokines There were no significant unadjusted associations between either interleukin-1 alpha or tumor necrosis factor and any demographic or physiological variables. Participants who reported no drug use in their lifetime were 2.14 (95 % CI 1.01, 4.54) times more likely to have higher levels of tumor necrosis factor than their marijuana only using counterparts. Marijuana and other drug users were more likely to have higher tumor necrosis factor levels in comparison to their marijuana using counterparts, though this relationship was not significant (OR 1.96, 95 % CI 0.84, 4.55). There was no association between drug use and interleukin-1 alpha. These results can be found in Table 2 and depictions of these relationships are seen in Figs. 1 and 2.
Adjusted associations between lifetime drug use and cytokines
As seen in Table 2 , in the presence of all demographic and physiological variables, drug use was not significantly associated with interleukin-1 alpha. Non-drug users were 2.73 (95 % CI 1.18, 6.31) times more likely than marijuana only users to have higher tumor necrosis factor.
Discussion
The current study examined the associations between selfreported lifetime drug use, interleukin-1 alpha and tumor necrosis factor. The non-drug users were over two times more likely to have higher tumor necrosis factor levels than their marijuana only using counterparts were. In the presence of physiological and demographic covariates, the relationship between self-reported lifetime drug use and tumor necrosis factor levels slightly increased in strength.
No relationship emerged between lifetime drug use and interleukin-1 alpha levels. These results support previous literature, which presented lower levels of proinflammatory cytokine interleukin-6 in marijuana only users in comparison to other subgroups (Keen et al., 2014) . In addition, these results are consistent with cellular level research that indicates cannabinoids decrease tumor necrosis factor levels (Cabral & Vasquez, 1992; Klein et al., 2000; Kusher et al., 1994) . Interleukin-6, interleukin-1 alpha, and tumor necrosis factor are three of the primary cytokines involved in the brain-immune system connection through sickness behavior (Maier & Watkins, 1998) . Interestingly, there was a differentiation in the effects of self-reported lifetime drug use and the cytokines interleukin-1 alpha and tumor necrosis factor in the current study. Specifically, lifetime drug use was associated with tumor necrosis factor, but not interleukin-1 alpha. Given that interleukin-6 also has anti-inflammatory properties, including the ability to down regulate tumor necrosis factor, it is possible that the current findings align with previous research (Keen et al., 2014) and are based on this specific cytokine network. Though tumor necrosis factor and interleukin-1 alpha are both involved in clotting, con- nective tissue remodeling or even tissue destruction, the present study presents a differentiation in tumor necrosis factor and interleukin-1 alpha function based on lifetime drug use. Moreover, the biological influences of tumor necrosis factor and interleukin-1 alpha differ mainly in the fact that tumor necrosis factor is a part of the apoptotic domain or cell death, whereas inteleukin-1 has no death domain (Feldman et al., 2000) . This may be connected to marijuana's immunosuppressive influence. Overall, the levels of TNF seemed to be within range of other normal or average subsamples reported in the literature. The TNF levels of in the current sample of African Americans were lower than symptomatic HIV-1 positive participants presented by Roux-Lombard, Modoux, Cruchaud, and Dayer (1989) , but very close to the HIV-1 asymptomatic subsample in the same study. The current sample's median value was well below levels presented in patients with congestive or chronic heart failure (Levine et al., 1990; Testa et al., 1996) . However, the ''normal'' control group in the heart failure study presented by Feldman et al. (2000) had very similar values to the levels presented in this sample. The TNF levels in the current sample were also consistent with a subsample of smokers and lower than a subsample of participants with asthma (Keatings, Collins, Scott, & Barnes, 1995) . However, the median values of Interleukin-1 alpha in the current sample were also more than double the levels in the young adult to middle-aged sample of smokers presented by Yang et al. (2014) . Additionally, Interleukin-1 alpha levels were higher than those reported in a sample of senile or cognitively impaired Chinese sample (Li et al., 2011 ).
In the current study, the groups differed significantly based on covariates age and sex. Specifically, the marijuana using group was younger and predominately male. This is consistent with prevalence statistics and previous literature (Degenhardt et al., 2008) . Though this is a community-based sample of African Americans, these findings suggest that there may be a sub group of younger males driving the differences among the groups based on their recreational use of marijuana. Historically, previous research has suggested males are more likely to experience substance abuse based on national trends (Brady and Randall, 1999) . However, there is also a sex difference suggested based in proinflammatory markers (Sperry et al., 2008) . Moreover, there is potential age-related changes in proinflammatory markers that may cause potential variations in the results (O'Mahony et al., 1998; Stowe, Peek, Cutchin, & Goodwin, 2010) . Specifically, older individuals experience increases in proinflammatory markers, such as IL-6, IL-1 receptor agonists, and C-reactive protein (Ferrucci et al., 2005) . Taken together, further research is necessary to elucidate the relationship between marijuana use and proinflammatory markers. Age and sex may have orthogonal influence upon the relationship between recreational marijuana use, but a priori design and analyses are necessary to continue exploring the this issue. Identifying differential effects based on age and sex will further the knowledge base and allow researchers to tailor interventions or research methodology for subgroups within the African American communities.
Our findings are subject to limitations. First, the subjects in the current study were non-fasting at time of blood draw and the time of blood draw was between 9 a.m. and 6 p.m. In addition, patients reported taking medications, but other than our exclusion criteria (psychological disorders and brain trauma), we do not know what the intended use or names of these medications. Lastly, the parent study did not measure frequency of illicit drug use, thus leaving the current study unable to examine the association between frequencies of illicit drug use and resting cytokine levels and limiting generalizability to cannabis and illicit drug users.
The current findings support the growing literature positing the immunosuppressive influence of marijuana use. This preliminary study also presents a potential differentiation in marijuana's influence on the immune system, as non-drug users were more likely to have higher tumor necrosis factor but not interleukin-1 alpha than marijuana use only counterparts were. Future research should further identify other proinflammatory or immune agents that are influenced by marijuana use in various diseased and healthy sample types. Further exploration will allow for extrapolation to both frequent and moderate marijuana users. This is especially important given the legalization efforts and prevalence of marijuana use in the United States.
